Transcatheter closure of patent foramen ovale (PFO) and secundum type atrial septal defect
(ASD) are common transcatheter procedures. Although they share many technical details …

Highlights•TTE with contrast study is being used for indirect diagnosis of PFO.•TEE affords
direct visualization of PFO with measurement of PFO size.•TEE also provides detailed …

The incidence of atrial septal defect (ASD) is 1 in 1000 live births and account up to one third
of the acyanotic shunts in the adult population.(Brickner et al. 2000; Yared et al. 2009) …

Percutaneous closure of a patent foramen ovale (PFO) and atrial septal defect (ASD) is
performed frequently. Especially PFO closure has been a subject for discussion but has …

Imaging is fundamental for successful patent foramen ovale (PFO) closure and consists of
preprocedural imaging, procedural guidance, and postprocedural assessment …

Objectives: The aim of the study was to evaluate safety, efficacy, and long‐term clinical
outcome of percutaneous closure of patent foramen ovale (PFO closure) in a low volume …

Aims The GORE® CARDIOFORM Septal Occluder (GSO) is a novel device designed for
rapid and effective closure of patent foramen ovale (PFO) which has distinctive features …

In 2001, the US Food and Drug Administration approved the use of septal occluder devices
for closing atrial septal defects and patent foramen ovale (PFO). Soon, many tertiary centers …

Closing a patent foramen ovale (PFO) under guidance with intracardiac echocardiography
(ICE) affords multiple advantages compared to guidance with transesophageal …

Background. The presence of patent foramen ovale (PFO) has been linked to many illness,
including cryptogenic stroke, transient ischemic attack, migraine, platypnea-orthodeoxia …